мȸ ǥ ʷ

ǥ : ȣ - 540247   51 
Benefit of Manual Thrombectomy in Limiting Infarct Expansion during Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction
전남대학교병원 순환기내과, 전남대학교병원 영상의학화
심두선, 안영근, 김윤현, 최송, 선현주, 고점석, 이민구, 박근호, 윤현주, 윤남식, 홍영준, 박형욱, 김주한, 정명호, 조정관, 박종춘, 강정채
Background: The role of manual thrombectomy (MT) during primary percutaneous coronary intervention (PCI) remains open for further exploration. We sought to assess whether MT could reduce infarct size (IS) in patients with acute ST-elevation MI (STEMI) undergoing primary PCI. Methods: Between April 2009 and April 2010, 40 consecutive patients presenting with first acute STEMI (Killip≤II) within 12 hours after the symptom onset were randomized to manual thrombectomy (MT) (group I, N=20) or conventional PCI without MT (group II, N=20). The use of glycoprotein IIb/IIIa inhibitor (GPI) was left to the discretion of the operator. All patients received a 600-mg loading dose of clopidogrel before PCI and underwent delayed enhanced (DE) MDCT immediately after PCI without injection of an additional contrast media for assessment of IS, determined as the total volume of myocardium showing DE. DE MDCT was repeated at 2 months after PCI. The primary endpoint was IS reduction at 2 months. Results: Baseline clinical characteristics and angiographic findings were similar between the two groups. There were no differences between group I and II in symptom-to-door time (234±191 min vs. 232±158 min), door-to-balloon time (83±55 min vs. 80±30 min), PCI-to-MDCT time (17±19 min vs. 15±7 min), Pre-PCI TIMI 0/1, post-PCI TIMI 3, and stent diameter and length. The use of drug-eluting stents was similar, but GPI was less likely to be used in group I than group II (30.0% vs. 63.2%, p=0.038). Markers of myocardial reperfusion were better in group I but not statistically different: ST-resolution rate >70% (64.7% vs. 57.9%), myocardial blush grade 3 (85.0% vs. 68.4%), and corrected TIMI frame count <28 (27.8% vs. 15.8%). However, group I had more reduced IS measured by DE MDCT (15.6±15.8 ml vs. 29.5±25.2 ml, p=0.048) as well as biomarkers (CK: 1,447 U/L vs. 3,328 U/L, p=0.0004; CK-MB: 90 U/L vs. 177 U/L, p=0.010). LV ejection fraction (LVEF) after PCI was better in group I but not statistically significant (58.7±10.2% vs. 53.3±8.9%, p=0.086). In multiple linear regression analysis, correlates of IS were the presence of anterior MI (B=19.9, 95% CI=5.28~34.5, p=0.010) and the use of MT (B=-13.3, 95% CI=-25.7~-0.91, p=0.036). GPI use, total volume of contrast media, and time between the last contrast injection and CT scan were not associated with IS. At 2 months, clinical outcome was similar between the groups. Still, group I maintained reduced IS (13.1±8.5 ml vs. 20.9±10.5 ml, p=0.072) and improved LVEF (63.1±6.5% vs. 53.6±14.8%, p=0.042). Conclusion: MT during primary PCI for acute STEMI was effective in limiting infarct expansion and improving LV function.


[ư]


logo 학술대회일정 사전등록안내 초록등록안내 초록등록/관리 숙박 및 교통 안내 전시 및 광고